Molecular genetic abnormalities in patients with T-cell acute lymphoblastic leukemia: a literature review
T-cell acute lymphoblastic leukemia/lymphoma (T-ALL) is an aggressive hematological disease. Modern polychemotherapy protocols allow achieving a 5-year overall survival of 60–90 % in different age groups, however, relapses and refractory forms of T-ALL remain incurable. Over the past decades, the pa...
Main Authors: | A. N. Vasileva, O. A. Aleshina, B. V. Biderman, A. B. Sudarikov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2022-11-01
|
Series: | Онкогематология |
Subjects: | |
Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/599 |
Similar Items
-
T-Cell Acute Lymphoblastic Leukemia—Current Concepts in Molecular Biology and Management
by: Parveen Shiraz, et al.
Published: (2021-11-01) -
Change of lipid profile in children with acute lymphoblastic leukemia due to induction chemotherapy in a tertiary care hospital of Bangladesh
by: Rasel Siddique, et al.
Published: (2023-04-01) -
Change of lipid profile in children with acute lymphoblastic leukemia due to induction chemotherapy in a tertiary care hospital of Bangladesh
by: Rasel Siddique, et al.
Published: (2023-04-01) -
Genetic ancestry, differential gene expression, and survival in pediatric B‐cell acute lymphoblastic leukemia
by: Freddy A. Barragan, et al.
Published: (2023-02-01) -
Gene Mutations Related to Glucocorticoid Resistance in Pediatric Acute Lymphoblastic Leukemia
by: JinFang Zhang, et al.
Published: (2022-06-01)